Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle

被引:144
|
作者
Chittajallu, R [1 ]
Chen, Y [1 ]
Wang, H [1 ]
Yuan, X [1 ]
Ghiani, CA [1 ]
Heckman, T [1 ]
McBain, CJ [1 ]
Gallo, V [1 ]
机构
[1] NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1073/pnas.042698399
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Proliferative oligodendrocyte progenitor cells (OPs) express large, delayed outward-rectifying K+ currents (l(K)), whereas nondividing immature and mature oligodendrocytes display much smaller l(K.) Here, we show that up-regulation Of l(K) occurs in G, phase of the cell cycle in purified cultured OPs and is the result of an RNA synthesis-dependent, selective increase of the K+ channel subunit proteins Kv1.3 and Kv1.5. In oligodendrocyte cells acutely isolated from developing rat brain, a decrease of cyclin D expression is observed as these cells mature along their lineage. This is accompanied by a decrease in Kv1.3 and Kv1.5 subunit expression, suggesting a role for these subunits in the proliferative potential of OPs in situ. l(K) expressed in OPs in subventricular zone and developing white matter in acutely isolated slice preparations were selectively blocked by antagonists of Kv1.3, illustrating the functional presence of this subunit in situ. Interestingly, Kv1.3 block inhibited S-phase entry of both purified OPs in culture and in tissue slice cultures. Thus, we employ both in vitro and in situ experimental approaches to show that (i) RNA-dependent synthesis of Kv1.3 and Kv1.5 subunit proteins occurs in G(1) phase of the OP cell cycle and is responsible for the observed increase in l(K), and (ii) currents through Kv1.3-containing channels play a crucial role in G(1)/S transition of proliferating OPs.
引用
收藏
页码:2350 / 2355
页数:6
相关论文
共 50 条
  • [42] Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer
    Wikman, Harriet
    Kettunen, Eeva
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (04) : 515 - 530
  • [43] Protein kinase C δ stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest
    Fikaris, AJ
    Kao, GD
    Brown, EJ
    Kazanietz, MG
    Meinkoth, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (37) : 32107 - 32114
  • [44] lnvadopodia are enriched in the G1 phase of the cell cycle
    Bayarmagnai, B.
    Perrin, L.
    Pourfarhangi, K. Esmaeili
    Gligorijevic, B.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26) : 227 - 227
  • [45] Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G1 to S Phase
    Murthy, Shalini
    Wu, Min
    Bai, V. Uma
    Hou, Zizheng
    Menon, Mani
    Barrack, Evelyn R.
    Kim, Sahn-Ho
    Reddy, G. Prem-Veer
    PLOS ONE, 2013, 8 (02):
  • [46] A structural role of androgen receptor in progression of prostate cancer cells from G1 to S phase
    Murthy, Shalini
    Chinnakannu, Kannagi
    Wu, Min
    Kim, Sahn-Ho
    Barrack, Evelyn R.
    Reddy, Prem-Veer G.
    CANCER RESEARCH, 2012, 72
  • [47] Astrocyte progression from G1 to S phase of the cell cycle depends upon multiple protein interaction
    Pedram, A
    Razandi, M
    Hu, RM
    Levin, ER
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) : 13966 - 13972
  • [48] Hygrolidin induces p21 expression and abrogates cell cycle progression at G1 and S phases
    Kawada, M
    Usami, I
    Ohba, S
    Someno, T
    Kim, JW
    Hayakawa, Y
    Nose, K
    Ishizuka, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (01) : 178 - 183
  • [49] CYCLOPENTENONE PROSTAGLANDINS BLOCK CELL-CYCLE PROGRESSION IN THE G1 PHASE AND INDUCE THE G1-SPECIFIC PROTEINS IN HELA S3 CELLS
    NARUMIYA, S
    OHNO, K
    FUKUSHIMA, M
    FUJIWARA, M
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 411 - 414
  • [50] A POTENTIAL ROLE FOR C-JUN IN CELL-CYCLE PROGRESSION THROUGH LATE G1 AND S
    CARTER, R
    COSENZA, SC
    PENA, A
    LIPSON, K
    SOPRANO, DR
    SOPRANO, KJ
    ONCOGENE, 1991, 6 (02) : 229 - 235